Chicago Partners Investment Group LLC Lowers Holdings in HCA Healthcare, Inc. $HCA

Chicago Partners Investment Group LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 49.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,761 shares of the company’s stock after selling 1,713 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in HCA Healthcare were worth $830,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC purchased a new stake in HCA Healthcare during the fourth quarter worth $1,021,000. NewEdge Advisors LLC raised its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC grew its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. boosted its position in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Some analysts remain constructive, with one Seeking Alpha piece arguing HCA’s recent underperformance may already reflect the biggest policy and margin concerns, and that the stock could be set up for a rebound if fundamentals stabilize.
• Neutral Sentiment: Barclays lowered its price target on HCA Healthcare from $427 to $402 and kept an equal-weight rating, signaling a more cautious near-term view even though the new target still implies modest upside from current levels. Barclays Cuts HCA Price Target
• Neutral Sentiment: Several articles noted that HCA’s stock still looks discounted relative to its long-term earnings power, but valuation arguments may be offset by growing concerns around reimbursement pressure and insurance coverage losses.
• Negative Sentiment: HCA cut its 2026 earnings outlook after reporting that federal policy changes, a worsening payer mix, and more uninsured patients could reduce profits by roughly $1 billion, raising concerns about margin compression and slower growth. HCA Cuts 2026 Earnings Forecast
• Negative Sentiment: Reports also highlighted a $400 million hit linked to policy changes and weaker earnings quality, since part of the quarterly beat was helped by a one-time Medicaid payment rather than underlying operating strength.
• Negative Sentiment: Labor and contract issues at one HCA hospital added another headline risk, though this appears less material than the company’s earnings and policy-related pressures.

HCA Healthcare Trading Up 1.8%

Shares of NYSE HCA opened at $385.71 on Friday. The company has a 50-day moving average of $393.51 and a 200 day moving average of $457.65. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market cap of $85.57 billion, a PE ratio of 13.26, a P/E/G ratio of 1.25 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the company earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.77 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. KeyCorp reduced their target price on HCA Healthcare from $510.00 to $475.00 and set an “overweight” rating for the company in a research note on Tuesday. Cantor Fitzgerald reduced their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research report on Thursday, June 4th. Finally, Robert W. Baird cut their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $486.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.